Real-World Effectiveness and Safety of Risankizumab in Adult Patients with Plaque Psoriasis: A 16-Week International Multicenter Retrospective Cohort Study.

Autor: Bagit A; Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada., Maliyar K; Division of Dermatology, Department of Medicine, University of Toronto, Toronto, ON, Canada., Mansour M; Division of Dermatology, Department of Medicine, University of Toronto, Toronto, ON, Canada., Georgakopoulos JR; Division of Dermatology, Department of Medicine, University of Toronto, Toronto, ON, Canada., Rankin BD; Division of Dermatology, Department of Medicine, University of Calgary, Calgary, AB, Canada., Lytvyn Y; Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.; Division of Dermatology, Department of Medicine, University of Toronto, Toronto, ON, Canada., Zaaroura H; Division of Dermatology, Department of Medicine, University of Toronto, Toronto, ON, Canada., Park YJ; Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada., Wang OJE; Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada., Mufti A; Division of Dermatology, Department of Medicine, University of Toronto, Toronto, ON, Canada.; Division of Dermatology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada., Torres T; Department of Dermatology, Centro Hospitalar de Santo António, Porto, Portugal.; Instituto de Ciências Biomédicas Abel Salazar, University of Porto, Porto, Portugal., Le AM; Department of Dermatology, Centro Hospitalar de Santo António, Porto, Portugal., Vender R; Dermatrials Research Inc and Venderm Consulting, Hamilton, ON, Canada., Prajapati VH; Division of Dermatology, Department of Medicine, University of Calgary, Calgary, AB, Canada.; Dermatology Research Institute, Calgary, AB, Canada.; Probity Medical Research, Calgary, AB, Canada.; Skin Health & Wellness Centre, Calgary, AB, Canada.; Section of Community Pediatrics, University of Calgary, Calgary, AB, Canada.; Section of Pediatric Rheumatology, Department of Pediatrics, University of Calgary, Calgary, AB, Canada., Yeung J; Division of Dermatology, Department of Medicine, University of Toronto, Toronto, ON, Canada.; Division of Dermatology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.; Division of Dermatology, Women's College Hospital, Toronto, ON, Canada.; Probity Medical Research, Waterloo, ON, Canada.

Publikováno v: Journal of cutaneous medicine and surgery [J Cutan Med Surg] 2024 Nov-Dec; Vol. 28 (6), pp. 604-605. Date of Electronic Publication: 2024 Sep 03.

Effectiveness and Safety of Upadacitinib in Adolescent and Adult Patients with Atopic Dermatitis: An Analysis of Long-Term (Week 52) Data from a Real-World Multicenter Retrospective Review.

Autor: Rankin BD; Department of Medicine, Division of Dermatology, University of Calgary, Calgary, Canada., Sood S; Temerty Faculty of Medicine, University of Toronto, Toronto, Canada., Park YJ; Temerty Faculty of Medicine, University of Toronto, Toronto, Canada., Rimke A; Dermatology Research Institute, Calgary, Canada., Abduelmula A; Department of Medicine, Division of Dermatology, University of Toronto, Toronto, Canada., Georgakopoulos JR; Department of Medicine, Division of Dermatology, University of Toronto, Toronto, Canada., Maliyar K; Department of Medicine, Division of Dermatology, University of Toronto, Toronto, Canada., Leung F; Dermatology Research Institute, Calgary, Canada.; Skin Health & Wellness Centre, Calgary, Canada., Stark LA; Dermatology Research Institute, Calgary, Canada.; Skin Health & Wellness Centre, Calgary, Canada., Devani AR; Dermatology Research Institute, Calgary, Canada.; Skin Health & Wellness Centre, Calgary, Canada.; Probity Medical Research, Waterloo, Canada., Yeung J; Department of Medicine, Division of Dermatology, University of Toronto, Toronto, Canada.; Probity Medical Research, Waterloo, Canada.; Department of Medicine, Division of Dermatology, Women's College Hospital, Toronto, Canada.; Department of Medicine, Division of Dermatology, Sunnybrook Health Sciences Centre, Toronto, Canada., Prajapati VH; Department of Medicine, Division of Dermatology, University of Calgary, Calgary, Canada.; Dermatology Research Institute, Calgary, Canada.; Skin Health & Wellness Centre, Calgary, Canada.; Probity Medical Research, Waterloo, Canada.; Section of Community Pediatrics, Department of Pediatrics, University of Calgary, Calgary, Canada.; Section of Pediatric Rheumatology, Department of Pediatrics, University of Calgary, Calgary, Canada.

Publikováno v: Dermatitis : contact, atopic, occupational, drug [Dermatitis] 2024 Oct 24. Date of Electronic Publication: 2024 Oct 24.

Effectiveness and safety of risankizumab dose optimization in adult patients with plaque psoriasis: An international multicentre retrospective cohort study.

Autor: Bagit A; Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada., Maliyar K; Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada., Mansour M; Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada., Georgakopoulos JR; Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada., Rankin B; Division of Dermatology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada., Lytvyn Y; Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.; Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada., Zaaroura H; Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada., Park YJ; Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada., Wang E; Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada., Mufti A; Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.; Division of Dermatology, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada., Torres T; Department of Dermatology, Centro Hospitalar de Santo António, Porto, Portugal.; Instituto de Ciências Biomédicas Abel Salazar, University of Porto, Porto, Portugal., Le AM; Department of Dermatology, Centro Hospitalar de Santo António, Porto, Portugal., Vender R; Dermatrials Research Inc. and Venderm Consulting, Hamilton, Ontario, Canada., Prajapati VH; Division of Dermatology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada.; Dermatology Research Institute, Calgary, Alberta, Canada.; Probity Medical Research, Calgary, Alberta, Canada.; Skin Health & Wellness Centre, Calgary, Alberta, Canada.; Section of Community Pediatrics, University of Calgary, Calgary, Alberta, Canada.; Section of Pediatric Rheumatology, Department of Pediatrics, University of Calgary, Calgary, Alberta, Canada., Yeung J; Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.; Division of Dermatology, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.; Division of Dermatology, Women's College Hospital, Toronto, Ontario, Canada.; Probity Medical Research, Toronto, Ontario, Canada.

Publikováno v: Journal of the European Academy of Dermatology and Venereology : JEADV [J Eur Acad Dermatol Venereol] 2024 Oct 15. Date of Electronic Publication: 2024 Oct 15.

Real-world effectiveness and safety of risankizumab in adult patients with plaque psoriasis: A 1-year international multicenter retrospective cohort study.

Autor: Bagit A; Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada., Maliyar K; Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada., Mansour M; Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada., Georgakopoulos JR; Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada., Rankin B; Division of Dermatology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada., Lytvyn Y; Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada; Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada., Zaaroura H; Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada., Park YJ; Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada., Wang E; Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada., Mufti A; Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Division of Dermatology, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada., Torres T; Department of Dermatology, Centro Hospitalar de Santo António, Porto, Portugal; Instituto de Ciências Biomédicas Abel Salazar, University of Porto, Porto, Portugal., Le AM; Department of Dermatology, Centro Hospitalar de Santo António, Porto, Portugal., Vender R; Dermatrials Research Inc. and Venderm Consulting, Hamilton, Ontario, Canada., Prajapati VH; Division of Dermatology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada; Dermatology Research Institute, Calgary, Alberta, Canada; Probity Medical Research, Calgary, Alberta, Canada; Skin Health & Wellness Centre, Calgary, Alberta, Canada; Section of Community Pediatrics, University of Calgary, Calgary, Alberta, Canada; Section of Pediatric Rheumatology, Department of Pediatrics, University of Calgary, Calgary, Alberta, Canada., Yeung J; Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Division of Dermatology, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada; Division of Dermatology, Women's College Hospital, Toronto, Ontario, Canada; Probity Medical Research, Toronto, Ontario, Canada. Electronic address: jensen.yeung@utoronto.ca.

Publikováno v: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2024 Sep; Vol. 91 (3), pp. 513-515. Date of Electronic Publication: 2024 Apr 25.

Real-world experience of bimekizumab for plaque psoriasis in adult patients with prior exposure to interleukin-17 inhibitors: A 16-week multicenter retrospective review.

Autor: Sood S; Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada., Rimke A; Dermatology Research Institute, Calgary, Alberta, Canada., Rankin BD; Division of Dermatology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada., Abduelmula A; Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada., Georgakopoulos JR; Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada., Maliyar K; Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada., Bagit A; Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada., Leung F; Skin Health & Wellness Centre, Calgary, Alberta, Canada., Devani AR; Dermatology Research Institute, Calgary, Alberta, Canada; Skin Health & Wellness Centre, Calgary, Alberta, Canada; Probity Medical Research, Waterloo, Ontario, Canada., Vender R; Division of Dermatology, McMaster University, Hamilton, Ontario, Canada; Dermatrials Research Inc. & Venderm Consulting, Hamilton, Ontario, Canada., Yeung J; Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Probity Medical Research, Waterloo, Ontario, Canada; Division of Dermatology, Department of Medicine, Women's College Hospital, Toronto, Ontario, Canada; Division of Dermatology, Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada., Prajapati VH; Dermatology Research Institute, Calgary, Alberta, Canada; Division of Dermatology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada; Skin Health & Wellness Centre, Calgary, Alberta, Canada; Division of Dermatology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada; Section of Community Pediatrics, Department of Pediatrics, University of Calgary, Calgary, Alberta, Canada; Section of Pediatric Rheumatology, Department of Pediatrics, University of Calgary, Calgary, Alberta, Canada. Electronic address: vimal@dermatologyresearch.ca.

Publikováno v: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2024 Aug 23. Date of Electronic Publication: 2024 Aug 23.